Skip to main content
CandipediaResearch

Symptoms & conditionsSafety guide

Serious fungal infections — who needs assessment and when

Use observable symptoms and health context to choose routine, prompt, or emergency care without treating them as proof of an invasive fungal infection.

Answer

Do not try to identify an invasive fungal infection from symptoms or a risk factor. Arrange assessment when a possible fungal problem occurs with weakened immunity, major recent healthcare exposure, unexplained adult oral thrush, pain or difficulty swallowing, or worsening despite treatment; use emergency care for the listed observable emergency features.

  • Serious invasive candidiasis is concentrated in people who are hospitalized, medically complex, or substantially immunocompromised, but risk context alone does not establish an infection.
  • Fever, chills, swallowing symptoms, or other systemic illness features are not specific to Candida; suspected invasive disease needs clinical assessment and testing, not self-care.
  • Suspected or confirmed Candida auris infection or colonization belongs in healthcare and infection-control management, not an ordinary self-treatment pathway.
Confidence
Strong confidence in keeping invasive disease outside self-care and using risk context plus observable care triggers; no symptom list can identify the cause for an individual.
Why
Current CDC guidance, global and IDSA candidiasis guidelines, NIH guidance, and current US care authorities agree that serious fungal disease is nonspecific, risk-dependent, test-dependent, and professionally managed.
Who this applies to
  • Children and adults in the United States with a possible fungal symptom and cancer treatment, transplant, HIV, another weakened-immune-system condition or therapy, recent hospitalization, major surgery, an invasive device, critical illness, dialysis, diabetes, or another complex healthcare context.
  • People with unexplained adult thrush-like mouth changes, pain or difficulty swallowing, a known or suspected infection that is not improving or is worsening, or concern about Candida auris after healthcare exposure.
Who needs a different route
  • People with a stable, localized mouth, skin, nail, or foot concern and none of the listed risk or worsening contexts; use the relevant problem-orientation route for assessment rather than assuming invasive disease.
  • People seeking a diagnosis, probability estimate, or antifungal regimen from symptoms, a photograph, a risk factor, or this page; invasive and healthcare-associated infections require clinical and laboratory assessment.

Next steps

  1. Contact the treating team — If weakened immunity, cancer treatment, transplant, major healthcare exposure, or an invasive device accompanies a possible fungal symptom, contact the treating healthcare provider and describe the symptom, timing, care exposure, medicines, and any recent treatment response.
  2. Get prompt reassessment — If a known or suspected infection is not getting better or is getting worse, get medical care immediately and ask whether emergency-department assessment is needed; do not explain worsening with a fungal label.
  3. Use emergency care for observable danger — With a known or suspected infection plus clammy skin, confusion, extreme pain, fever with shivering or feeling very cold, a high heart rate or weak pulse, or shortness of breath, call 911 or go to the nearest emergency department now.

Safety and when to get care

This route is based on the observable trigger and does not identify a diagnosis.

  • Care tier: Routine care

    Observable trigger
    A person needs a nonemergency in-person assessment for a mouth, skin, nail, foot, or possible fungal concern and does not have a regular clinician or dentist.
    What to do
    Use the HRSA Find a Health Center service to locate a nearby federally funded health center, then ask the center whether it provides the needed primary, dental, or referral service.
    Exact population
    • people in the United States who need nonemergency assessment and do not have an established care source
    Not covered here
    • people with an immediate medical emergency
    • people disclosing suicidal thoughts, inability to stay safe, or acute emotional crisis
    Source

  • Care tier: Routine care

    Observable trigger
    A person with cancer treatment, transplant, HIV or another weakened-immune-system condition or therapy develops a possible fungal symptom or an infection being treated is not getting better.
    What to do
    Contact the treating healthcare provider about the symptom, risk context, and whether condition-specific fungal testing or treatment review is needed.
    Exact population
    • people in the United States with a weakened immune system or listed high-risk treatment and the observable concern
    Not covered here
    • people without a listed high-risk context
    • people with sepsis features or another immediate medical emergency
    Source

  • Care tier: Prompt care

    Observable trigger
    A person has thrush-like mouth changes or pain or difficulty swallowing and is living with HIV, receiving chemotherapy, taking immune-suppressing medicine, or otherwise has a weakened immune system.
    What to do
    Contact the treating healthcare team promptly for assessment and condition-specific testing; do not assume that mouth appearance alone identifies the cause or extent.
    Exact population
    • children and adults in the United States with the observable symptom and at least one listed immune-risk context
    Not covered here
    • people without a listed immune-risk context
    • people who cannot breathe or have another immediate medical emergency
    Source

  • Care tier: Routine care

    Observable trigger
    A person with diabetes notices foot tingling, burning, pain, loss of feeling, a color or temperature change, dry cracked skin, thick yellow toenails, athlete's-foot-like changes between the toes, an ingrown nail, blister, ulcer, or infected corn.
    What to do
    Visit the regular clinician or foot doctor for assessment rather than assuming the change is fungal or treating it without review.
    Exact population
    • people in the United States with diabetes and at least one listed foot or nail change
    Not covered here
    • people without diabetes
    • people with signs of infection plus sepsis features or another immediate medical emergency
    Source

  • Care tier: Prompt care

    Observable trigger
    A known or suspected infection is not getting better or is getting worse, without the sepsis features or immediate danger listed in the emergency record.
    What to do
    Get medical care immediately and ask the healthcare professional whether emergency-department assessment is needed; do not use a fungal label to explain away worsening.
    Exact population
    • children and adults in the United States with the observable worsening or nonresponse
    Not covered here
    • people with clammy skin, confusion, extreme pain, fever or shivering, a high heart rate or weak pulse, shortness of breath, or another immediate medical emergency
    Source

  • Care tier: Emergency care

    Observable trigger
    A person with a known or suspected infection has clammy or sweaty skin, confusion or disorientation, extreme pain or discomfort, fever with shivering or feeling very cold, a high heart rate or weak pulse, or shortness of breath.
    What to do
    Treat this as a medical emergency: call 911 for immediate assistance or go to the nearest emergency department now, and say that an infection and possible sepsis are concerns.
    Exact population
    • children and adults in the United States with a known or suspected infection and at least one listed observable sepsis feature
    Not covered here
    • people with a stable local symptom and none of the listed emergency features
    Source

In this pathway

Parent problem or section
Symptoms & conditions
Current topic
Serious fungal infections — who needs assessment and whenCurrent

Page trust and updates

First published
2026-07-15
Evidence as of
2026-07-15
Last updated
2026-07-15
Authorship
Candipedia Research
What changed
Complete initial draft based on the serious-or-urgent and US authority packs for Pathway C.

Sources behind these conclusions

Observable reasons to change the care route

Use the person’s current situation, not a presumed fungal diagnosis. Contact the treating team when a possible fungal symptom occurs with cancer treatment, transplant, HIV, another weakened-immune-system condition or therapy, or when an infection under treatment is not improving. Thrush-like mouth changes or pain or difficulty swallowing in this context need prompt assessment. A person with diabetes should have listed foot or nail changes assessed rather than treating them as proof of fungus. A known or suspected infection that is getting worse needs immediate medical care; clammy skin, confusion, extreme pain, fever with shivering or feeling very cold, a high heart rate or weak pulse, or shortness of breath are emergency triggers in that infection context.

Choose routine, prompt, or emergency care

For a stable nonemergency concern, contact the treating healthcare provider. If no regular clinician or dentist is available, use HRSA Find a Health Center and ask whether the site provides the needed service. For a known or suspected infection that is not improving or is worsening without the listed emergency features, get medical care immediately and ask whether emergency-department assessment is needed. For the listed emergency features or another immediate medical emergency, call 911 or go to the nearest emergency department now. None of these routes confirms that the cause is fungal.

Why this page cannot establish the cause or recommend self-care

Current authorities describe invasive candidiasis as a clinician-managed, test-dependent illness concentrated in hospitalized, medically complex, or substantially immunocompromised populations. Its symptoms are nonspecific. Candida auris colonization and infection are distinct and require specialized identification and healthcare infection-control management. Treatment persistence or worsening reopens the diagnosis, site, organism, host risk, exposure, treatment, adherence, and adverse-effect assessment; it does not by itself prove resistance or invasive disease. The canonical claim and safety records above provide the source, check, and expiry dates for every care statement on this draft.

Sources

View all 15 sources